Why the Baby-Formula Market Is a Mess: Low Competition, High Regulation
• By Jesse Newman and Annie GasparroThe WIC program and regulations tamp down competition, resulting in Similac and Enfamil controlling the bulk of an inflexible, $4 billion U.S. formula market. It cracked when a major factory halted production.
